AbbVie · 3 weeks ago
2026 Packaging Co-Op (July - Dec)
AbbVie is dedicated to discovering and delivering innovative medicines to solve serious health issues. The Packaging Engineering Co-Op role involves participating in a six-month program focused on packaging development and testing, providing students with meaningful assignments that impact the business and patients worldwide.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Packaging development and testing for new projects
Test protocol and test execution
Material identification, selection, and specifications
Data mining for standardization opportunities
Sustainability and packaging improvement opportunities
Qualification
Required
Currently enrolled in university, pursuing a Bachelor's in Packaging or related field
Must be returning to university the semester following your Co-Op
Expected graduation date between December 2026 - June 2028
Preferred
Excellent problem-solving, written, and verbal skills
Exceptional interpersonal, leadership and project management skills
Proven track record of teamwork, adaptability, innovation, initiative and integrity
Proficient in Microsoft Office Suite (Word, Excel, PowerPoint, Outlook, etc.)
Strong academic performance, GPA 3.0/4.0
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-11
2026-01-09
2026-01-09
Company data provided by crunchbase